- Home
- IBRX vs BWIN Comparison
IBRX vs BWIN Comparison
Compare IBRX & BWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBRX
- BWIN
- Stock Information
- Founded
- IBRX 2014
- BWIN 2011
- Country
- IBRX United States
- BWIN United States
- Employees
- IBRX N/A
- BWIN N/A
- Industry
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- BWIN Specialty Insurers
- Sector
- IBRX Health Care
- BWIN Finance
- Exchange
- IBRX Nasdaq
- BWIN Nasdaq
- Market Cap
- IBRX 2.3B
- BWIN 2.2B
- IPO Year
- IBRX N/A
- BWIN 2019
- Fundamental
- Price
- IBRX $2.53
- BWIN $28.63
- Analyst Decision
- IBRX Strong Buy
- BWIN Buy
- Analyst Count
- IBRX 6
- BWIN 8
- Target Price
- IBRX $9.83
- BWIN $44.00
- AVG Volume (30 Days)
- IBRX 10.3M
- BWIN 763.1K
- Earning Date
- IBRX 11-11-2025
- BWIN 11-03-2025
- Dividend Yield
- IBRX N/A
- BWIN N/A
- EPS Growth
- IBRX N/A
- BWIN N/A
- EPS
- IBRX N/A
- BWIN N/A
- Revenue
- IBRX $56,600,000.00
- BWIN $1,461,046,000.00
- Revenue This Year
- IBRX $629.94
- BWIN $11.08
- Revenue Next Year
- IBRX $109.91
- BWIN $13.16
- P/E Ratio
- IBRX N/A
- BWIN N/A
- Revenue Growth
- IBRX 4227.22
- BWIN 11.44
- 52 Week Low
- IBRX $1.83
- BWIN $26.33
- 52 Week High
- IBRX $7.48
- BWIN $55.82
- Technical
- Relative Strength Index (RSI)
- IBRX 47.77
- BWIN 41.96
- Support Level
- IBRX $2.42
- BWIN $27.54
- Resistance Level
- IBRX $2.75
- BWIN $28.84
- Average True Range (ATR)
- IBRX 0.13
- BWIN 1.09
- MACD
- IBRX -0.01
- BWIN 0.06
- Stochastic Oscillator
- IBRX 22.88
- BWIN 38.43
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
About BWIN The Baldwin Insurance Group Inc. Class A Common Stock
The Baldwin Insurance Group Inc is a United States-based insurance distribution firm. Its products include Business Insurance, Benefits Consulting, Reinsurance, Specialty MGA, Embedded Insurance., Personal insurance, etc.